Remedy (Extensive Report): Leveling up requires more patient play
Remedy is now building the next growth leap of its strategy with the 5 major game projects under development. This will be reflected in rising costs between 2022 and 2023, but enable significant earnings growth particularly in 2025-2026, driven by increasing royalty income. In terms of long-term growth potential, we see the share's risk/return ratio as attractive, but with our lowered forecasts, this will take longer to materialize than previously expected. Thus, in the short term, the attractiveness of the stock has weakened compared to our previous estimates.
Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.
Read more on company pageKey Estimate Figures2022-06-02
| 2021 | 22e | 23e | |
|---|---|---|---|
| Revenue | 44.7 | 48.1 | 46.6 |
| growth-% | 8.9 % | 7.4 % | -3.0 % |
| EBIT (adj.) | 11.4 | 6.7 | 0.6 |
| EBIT-% (adj.) | 25.5 % | 13.9 % | 1.4 % |
| EPS (adj.) | 0.67 | 0.39 | 0.03 |
| Dividend | 0.17 | 0.17 | 0.17 |
| Dividend % | 0.4 % | 1.1 % | 1.1 % |
| P/E (adj.) | 59.0 | 38.3 | 468.4 |
| EV/EBITDA | 33.0 | 17.3 | 45.7 |
Forum discussions
